Edition:
United States

Pfizer Inc (PFE.N)

PFE.N on New York Stock Exchange

35.97USD
23 May 2018
Change (% chg)

$0.25 (+0.70%)
Prev Close
$35.72
Open
$35.69
Day's High
$36.03
Day's Low
$35.63
Volume
6,214,583
Avg. Vol
7,810,534
52-wk High
$39.43
52-wk Low
$31.67

Chart for

About

Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines, as well as consumer healthcare products. The Company manages its commercial operations through two business... (more)

Overall

Beta: 0.99
Market Cap(Mil.): $214,682.30
Shares Outstanding(Mil.): 5,955.13
Dividend: 0.32
Yield (%): 3.55

Financials

  PFE.N Industry Sector
P/E (TTM): 26.26 30.95 32.75
EPS (TTM): 1.37 -- --
ROI: 6.00 14.84 14.38
ROE: 13.80 16.34 16.07

Australian anti-trust watchdog loses appeal against Pfizer over Lipitor sales

MELBOURNE An Australian court dismissed an appeal by the nation's anti-trust watchdog in a case against Pfizer Inc in which the regulator alleged the company had used its market power to limit competition for its cholesterol-lowering drug Lipitor.

May 25 2018

Australian anti-trust watchdog loses appeal against Pfizer over Lipitor sales

MELBOURNE, May 25 An Australian court dismissed an appeal by the nation's anti-trust watchdog in a case against Pfizer Inc in which the regulator alleged the company had used its market power to limit competition for its cholesterol-lowering drug Lipitor.

May 25 2018

Pfizer to pay $23.85 million to settle U.S. co-payment kickback probe

Pfizer Inc agreed to pay $23.85 million to resolve U.S. charges that it used a purportedly independent charity to pay illegal kickbacks to Medicare patients, covering their out-of-pocket costs for its prescription drugs.

May 24 2018

UPDATE 3-Pfizer to pay $23.85 mln to settle U.S. co-payment kickback probe

May 24 Pfizer Inc agreed to pay $23.85 million to resolve U.S. charges that it used a purportedly independent charity to pay illegal kickbacks to Medicare patients, covering their out-of-pocket costs for its prescription drugs.

May 24 2018

Drug maker Pfizer to pay $23.85 mln to settle claims it paid kickbacks

WASHINGTON, May 24 Drug maker Pfizer will pay $23.85 million to settle civil charges that it illegally paid kickbacks by using a foundation as a "conduit" to cover co-pay costs for Medicare patients taking three of the company's drugs, the U.S. Justice Department said Thursday.

May 24 2018

Pfizer to pay $23.85 mln to resolve U.S. kickbacks case

May 24 Pfizer Inc has agreed to pay $23.85 million to resolve allegations it illegally paid kickbacks to Medicare patients through a purportedly independent charitable foundation, the U.S. Department of Justice said on Thursday.

May 24 2018

BRIEF-FDA Grants Breakthrough Therapy Designation For Pfizer's Tafamidis

* FDA GRANTS BREAKTHROUGH THERAPY DESIGNATION FOR TAFAMIDIS FOR THE TREATMENT OF PATIENTS WITH TRANSTHYRETIN CARDIOMYOPATHY

May 23 2018

BRIEF-Pfizer Begins Phase 1/2 Study To Evaluate Respiratory Syncytial Virus Vaccine

* PFIZER BEGINS A PHASE 1/2 STUDY TO EVALUATE RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE Source text for Eikon: Further company coverage:

May 22 2018

Johnson & Johnson scraps Alzheimer's trials on safety concerns

Johnson and Johnson said it would stop mid-stage trials testing its experimental Alzheimer's drug after observing safety issues, the latest drugmaker to abandon developing treatments for the memory-robbing disease.

May 18 2018

BRIEF-Trial shows Pfizer's Lyrica reduces seizures in children with epilepsy

* LYRICA® (PREGABALIN) ORAL SOLUTION CV PHASE 3 TRIAL IN PEDIATRIC EPILEPSY MEETS PRIMARY ENDPOINT

May 17 2018

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $123.45 +0.54
Novartis AG (NOVN.S) CHF76.16 -0.52
Merck & Co., Inc. (MRK.N) $59.17 +0.72
Roche Holding Ltd. (ROG.S) CHF219.25 -4.65
Roche Holding Ltd. (RO.S) CHF223.40 -5.40
Abbott Laboratories (ABT.N) $61.84 +0.45
Bayer AG (BAYGn.DE) €102.74 -2.30
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €66.23 -0.14
AstraZeneca plc (AZN.L) 5,454.00 0.00

Earnings vs. Estimates